BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 4402388)

  • 1. [Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
    Lejwi G; Fabiato A; Gut JP; Gourgon R
    Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1654-68. PubMed ID: 4402388
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T; Takano M; Tamura A; Kubota H; Suzuki N
    Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of a new beta receptor blockader on hemodynamics].
    Bross W; Kustrzycki A; Olejak B; Bross T; Koltowski R; Masiak M
    Med Klin; 1972 Mar; 67(11):373-81. PubMed ID: 4401684
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a new beta-receptor blockader (LB 46, Visken) on systemic and pulmonary hemodynamics and on coronary blood flow in humans].
    Dolder M; Kaufmann M; Gurtner HP
    Schweiz Med Wochenschr; 1971 Dec; 101(51):1869-76. PubMed ID: 4400986
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemodynamic effects of oxprenolol in hypertensive patients.
    Majid PA; Sharma B; Saxton C; Stoker JB; Taylor SH
    Postgrad Med J; 1970 Nov; ():Suppl:67-72. PubMed ID: 4395462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of ICI 50,172 on cardio-respiratory parameters in dogs].
    Tavares P; Viana AR; Ximenes-Neto M; Martinelli JG
    Rev Bras Anestesiol; 1971; 21(4):596-601. PubMed ID: 4401689
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-pharmacological study on the cardiodynamic interaction between digitalis and the adrenergic beta blockader butidrine].
    Visioli O; Botti G; Tagliavini S; Chizzola A
    Clin Ter; 1968 May; 45(3):231-48. PubMed ID: 4390650
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of equi-antiarrhythmic doses of alprenolol (a beta-adrenergic receptor antagonist) diphenylhydantoin and procainamide.
    Proctor JD; Allen FJ; Wasserman AJ
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):354-67. PubMed ID: 4396926
    [No Abstract]   [Full Text] [Related]  

  • 12. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
    Miyazaki M; Fujita T
    Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic effects of intravenous oxoprenolol.
    Bensaid J; Scebat L; Lenegre J
    Postgrad Med J; 1970 Nov; ():Suppl:49-56. PubMed ID: 4395458
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies with a new beta receptor blocking agent from the indole series (LB 46)].
    Sterz H
    Wien Klin Wochenschr; 1970 Dec; 82(50):894-9. PubMed ID: 4099292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the effects of an beta-adrenolytic substance on the functional parameters of blood circulation].
    Noder W
    Z Kreislaufforsch; 1969 Apr; 58(4):440-7. PubMed ID: 5799929
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of LB-46, a new beta adrenergic blocking agent, on pulse and blood pressure at rest and after exercise in healthy volunteers.
    Mehta AB; Cooverji ND; Agrawal AB; Shah AC; Patnekar PN; Vora DD
    J Assoc Physicians India; 1971 Nov; 19(11):765-70. PubMed ID: 4399862
    [No Abstract]   [Full Text] [Related]  

  • 20. Some haemodynamic effects of LB 46 (Visken).
    Smyth AJ; Watson O; Peel JS; Turner AS
    N Z Med J; 1970 Oct; 72(461):246-7. PubMed ID: 4395124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.